7JXP

EGFR kinase (T790M/V948R) in complex with osimertinib and JBJ-04-125-02


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.16 Å
  • R-Value Free: 0.247 
  • R-Value Work: 0.212 
  • R-Value Observed: 0.214 

Starting Model: experimental
View more details

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history


Literature

Molecular basis for cooperative binding and synergy of ATP-site and allosteric EGFR inhibitors

Beyett, T.S.To, C.Heppner, D.E.Rana, J.K.Schmoker, A.M.Jang, J.De Clercq, D.J.H.Gomez, G.Scott, D.A.Gray, N.S.Janne, P.A.Eck, M.J.

(2022) Nat Commun 13: 2530


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Epidermal growth factor receptor331Homo sapiensMutation(s): 2 
Gene Names: EGFRERBBERBB1HER1
EC: 2.7.10.1
UniProt & NIH Common Fund Data Resources
Find proteins for P00533 (Homo sapiens)
Explore P00533 
Go to UniProtKB:  P00533
PHAROS:  P00533
GTEx:  ENSG00000146648 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP00533
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 4 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
JBJ (Subject of Investigation/LOI)
Query on JBJ

Download Ideal Coordinates CCD File 
I [auth D]
L [auth A]
M [auth C]
Q [auth F]
T [auth B]
I [auth D],
L [auth A],
M [auth C],
Q [auth F],
T [auth B],
U [auth E]
(2R)-2-(5-fluoro-2-hydroxyphenyl)-2-{1-oxo-6-[4-(piperazin-1-yl)phenyl]-1,3-dihydro-2H-isoindol-2-yl}-N-(1,3-thiazol-2-yl)acetamide
C29 H26 F N5 O3 S
VHQVOTINPRYDAO-AREMUKBSSA-N
ANP
Query on ANP

Download Ideal Coordinates CCD File 
G [auth D],
J [auth A],
O [auth F],
R [auth B]
PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER
C10 H17 N6 O12 P3
PVKSNHVPLWYQGJ-KQYNXXCUSA-N
YY3 (Subject of Investigation/LOI)
Query on YY3

Download Ideal Coordinates CCD File 
N [auth C],
V [auth E]
N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide
C28 H33 N7 O2
DUYJMQONPNNFPI-UHFFFAOYSA-N
MG
Query on MG

Download Ideal Coordinates CCD File 
H [auth D],
K [auth A],
P [auth F],
S [auth B]
MAGNESIUM ION
Mg
JLVVSXFLKOJNIY-UHFFFAOYSA-N
Binding Affinity Annotations 
IDSourceBinding Affinity
YY3 BindingDB:  7JXP Ki: min: 2.2, max: 434 (nM) from 6 assay(s)
IC50: min: 2.00e-3, max: 19 (nM) from 55 assay(s)
EC50: min: 6, max: 7930 (nM) from 19 assay(s)
JBJ BindingDB:  7JXP IC50: min: 0.26, max: 1000 (nM) from 8 assay(s)
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.16 Å
  • R-Value Free: 0.247 
  • R-Value Work: 0.212 
  • R-Value Observed: 0.214 
  • Space Group: P 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 57.113α = 70.56
b = 94.741β = 78.4
c = 95.569γ = 79.18
Software Package:
Software NamePurpose
PHENIXrefinement
xia2data scaling
PDB_EXTRACTdata extraction
xia2data reduction
PHASERphasing
Cootmodel building

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Cancer Institute (NIH/NCI)United States5R01CA201049-05
National Institutes of Health/National Cancer Institute (NIH/NCI)United States1F32CA247198-01

Revision History  (Full details and data files)

  • Version 1.0: 2021-09-08
    Type: Initial release
  • Version 1.1: 2022-05-18
    Changes: Database references
  • Version 1.2: 2023-10-18
    Changes: Data collection, Refinement description
  • Version 1.3: 2024-10-23
    Changes: Structure summary